Tartaric Acid
Medchemexpress LLC Fobrepodacin disodium | 1384984-20-6 | 99.5% | 552.40 g·mol-1 | C21H24FN6Na2O6P | 5 MG
Fobrepodacin disodium is the disodium phosphate salt form of an orally active prodrug developed as a gyrase B inhibitor with potent bactericidal activity against mycobacterial pathogens. Supplied as a white to off-white solid for research use, the material is characterized for purity, solubility, and storage to support in vitro and in vivo studies.
- Orally active phosphate prodrug
- Potent bactericidal activity in vivo
- High purity: 99.5%
- White to off-white solid; hygroscopic-store sealed
- Soluble in DMSO (~5 mg/mL) with pH adjustment recommended
- Stable in solvent: -80°C (6 months), -20°C (1 month)
Apexbio Technology LLC ENMD-2076 934353-76-1 200mg
ENMD-2076 (CAS 934353-76-1) is a selective inhibitor of Aurora A kinase (IC50 14 nM) and FLT3 (IC50 1 86 nM) with additional inhibitory activity against multiple tyrosine kinases implicated in angiogenesis and cell proliferation including RET FLT4/VEGFR3 SRC CSF1R NTRK1 FGFR1/2 VEGFR2/KDR LCK and PDGFR (IC50 1 86 120 nM) ENMD-2076 disrupts cell cycle progression by arresting cells in the G2/M phase through inhibition of Aurora kinases suppresses the PI3K/AKT signaling pathway and demonstrates cytotoxic effects in hematologic malignancy and solid tumor cell lines (in vitro IC50 25 700 nM) In vivo it reduces tumor growth and angiogenesis in xenograft models supporting its use in cancer research and antiangiogenic studies
Medchemexpress LLC DL-tartaric acid | 133-37-9 | MFCD00071626 | 98.0% | 150.09 g/mol | C4H6O6 | 1mL
DL-Tartaric acid is an orally active and non-racemic mixture of L- and D-tartaric acid with antioxidant activity 14C-labeled DL-Tartaric acid is nephrotoxic[1][2][3]
Medchemexpress LLC Fobrepodacin disodium | 1384984-20-6 | 99.5% | C21H24FN6Na2O6P | 10MG
Fobrepodacin disodium is the disodium phosphate prodrug of an aminobenzimidazole gyrase B/ParE inhibitor. It is an orally bioavailable antibacterial agent that demonstrates potent bactericidal activity in preclinical in vivo models, including mycobacterial infection studies. Supplied as a white to off-white solid, it is intended for research use in drug discovery and efficacy experiments.
- Orally bioavailable phosphate prodrug
- Potent bactericidal activity in vivo
- Suitable for preclinical efficacy and pharmacology studies
- White to off-white solid, convenient for formulation
- High purity (99.5%) for reproducible results
Medchemexpress LLC DL-tartaric acid | 133-37-9 | MFCD00071626 | 98.0% | 150.09 | C4H6O6 | 25g
DL-Tartaric acid is an orally active and non-racemic mixture of L- and D-tartaric acid with antioxidant activity 14C-labeled DL-Tartaric acid is nephrotoxic[1][2][3]
Chem-Impex International, Inc. D(-)-Tartaric acid | 147-71-7 | MFCD00004238 | 100G
D(-)-Tartaric acid, 147-71-7, MFCD00004238, 100G
Medchemexpress LLC DL-Tartaric acid | 133-37-9 | 98.0% | 150.09 | C4H6O6 | 500g
DL-Tartaric acid is an orally active and non-racemic mixture of L- and D-tartaric acid with antioxidant activity 14C-labeled DL-Tartaric acid is nephrotoxic[1][2][3]
Sigma Aldrich Fine Chemicals Biosciences DL-Tartaric acid | 133-37-9 | MFCD00071626
DL-Tartaric acid | Purity: 99% | MW: 150.09 | 133-37-9 | MFCD00071626
